Skip to main content

Table 1 Patients, donors and HPC products characteristics

From: Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells

Patients and donors characteristics

n (%)

ā€ƒallogeneic HSCT (RD)

12 (13%)

ā€ƒautologous HSCT

82 (87%)

Mobilisation

n (%)

ā€ƒrh-G-CSF

72 (77%)

ā€ƒrh-G-CSF + plerixafor

14 (15%)

ā€ƒmissing data

8 (8%)

Nb of apheresis collections

n (%)

ā€ƒ1

26 (28%)

ā€ƒ2

68 (72%)

Nb of grafts processed

n

Ā ā€ƒon same day

45

ā€ƒon different days

49

Median storage time (days)

n (min-max)

ā€ƒfor bags infused on same day

42 (9-296)

ā€ƒfor bags infused on different days

Ā 

ā€ƒ1st infusion

31 (10-141)

ā€ƒ2nd infusion

98 (41-190)

  1. Abbreviations
  2. HSCT : hematopoietic stem cell transplantation
  3. RD : related donor
  4. rh-G-CSF : recombinant human granulocyte colony-stimulating factor